Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Juvenescence moves IPO to second half of 2020

UK biotech valued at $500m will use public offering to move 5 life-extension technologies into phase 2 trials.

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.